The protective effects of lafutidine for bortezomib induced peripheral neuropathy

Abstract

Peripheral neuropathy (PN) caused by bortezomib is an important complication of multiple myeloma. Subcutaneous injection of bortezomib reduced PN, but 24% of cases were grade 2 PN and 6% of cases were grade 3 PN. PN higher than grade 2 was not resolved by subcutaneous injection. PN higher than grade 3 has serious dose limiting toxicity and is the cause of… (More)
DOI: 10.2147/JBM.S44127

Topics

2 Figures and Tables

Slides referencing similar topics